調査レポート | • レポートコード：QYR2104Z1072 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん幹細胞（CSC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞培養、細胞分離、細胞分析、分子分析、その他）、用途別市場規模（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん幹細胞（CSC）の市場動向 ・企業の競争状況、市場シェア ・がん幹細胞（CSC）の種類別市場規模（細胞培養、細胞分離、細胞分析、分子分析、その他） ・がん幹細胞（CSC）の用途別市場規模（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他） ・がん幹細胞（CSC）の北米市場規模2016-2027（アメリカ、カナダ） ・がん幹細胞（CSC）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん幹細胞（CSC）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん幹細胞（CSC）の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん幹細胞（CSC）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Abbvie、Merck Kgaa、Bionomics、Lonza、Stemline Therapeutics、Miltenyi Biotec、Promocell、Macrogenics、Oncomed Pharmaceuticals、Irvine Scientific、Stemcell Technologies、Sino Biological、Biotime） ・結論 |
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
Over the past few years, stem cells are being successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development or after tumor treatment.
Market Analysis and Insights: Global Cancer Stem Cells Market
The global Cancer Stem Cells market size is projected to reach US$ 1917.8 million by 2026, from US$ 858.9 million in 2019, at a CAGR of 12.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Stem Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Stem Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Stem Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Stem Cells market.
Global Cancer Stem Cells Scope and Market Size
Cancer Stem Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Segment by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
Abbvie
Merck Kgaa
Bionomics
Lonza
Stemline Therapeutics
Miltenyi Biotec
Promocell
Macrogenics
Bionomics
Lonza
Stemcell Technologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Stem Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Culturing
1.2.3 Cell Separation
1.2.4 Cell Analysis
1.2.5 Molecular Analysis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Stem Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Stem Cells Market Perspective (2016-2027)
2.2 Cancer Stem Cells Growth Trends by Regions
2.2.1 Cancer Stem Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Stem Cells Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Stem Cells Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Stem Cells Industry Dynamic
2.3.1 Cancer Stem Cells Market Trends
2.3.2 Cancer Stem Cells Market Drivers
2.3.3 Cancer Stem Cells Market Challenges
2.3.4 Cancer Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cells Players by Revenue
3.1.1 Global Top Cancer Stem Cells Players by Revenue (2016-2021)
3.1.2 Global Cancer Stem Cells Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Stem Cells Revenue
3.4 Global Cancer Stem Cells Market Concentration Ratio
3.4.1 Global Cancer Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Stem Cells Revenue in 2020
3.5 Cancer Stem Cells Key Players Head office and Area Served
3.6 Key Players Cancer Stem Cells Product Solution and Service
3.7 Date of Enter into Cancer Stem Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Stem Cells Breakdown Data by Type
4.1 Global Cancer Stem Cells Historic Market Size by Type (2016-2021)
4.2 Global Cancer Stem Cells Forecasted Market Size by Type (2022-2027)
5 Cancer Stem Cells Breakdown Data by Application
5.1 Global Cancer Stem Cells Historic Market Size by Application (2016-2021)
5.2 Global Cancer Stem Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Stem Cells Market Size (2016-2027)
6.2 North America Cancer Stem Cells Market Size by Type
6.2.1 North America Cancer Stem Cells Market Size by Type (2016-2021)
6.2.2 North America Cancer Stem Cells Market Size by Type (2022-2027)
6.2.3 North America Cancer Stem Cells Market Size by Type (2016-2027)
6.3 North America Cancer Stem Cells Market Size by Application
6.3.1 North America Cancer Stem Cells Market Size by Application (2016-2021)
6.3.2 North America Cancer Stem Cells Market Size by Application (2022-2027)
6.3.3 North America Cancer Stem Cells Market Size by Application (2016-2027)
6.4 North America Cancer Stem Cells Market Size by Country
6.4.1 North America Cancer Stem Cells Market Size by Country (2016-2021)
6.4.2 North America Cancer Stem Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Stem Cells Market Size (2016-2027)
7.2 Europe Cancer Stem Cells Market Size by Type
7.2.1 Europe Cancer Stem Cells Market Size by Type (2016-2021)
7.2.2 Europe Cancer Stem Cells Market Size by Type (2022-2027)
7.2.3 Europe Cancer Stem Cells Market Size by Type (2016-2027)
7.3 Europe Cancer Stem Cells Market Size by Application
7.3.1 Europe Cancer Stem Cells Market Size by Application (2016-2021)
7.3.2 Europe Cancer Stem Cells Market Size by Application (2022-2027)
7.3.3 Europe Cancer Stem Cells Market Size by Application (2016-2027)
7.4 Europe Cancer Stem Cells Market Size by Country
7.4.1 Europe Cancer Stem Cells Market Size by Country (2016-2021)
7.4.2 Europe Cancer Stem Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Stem Cells Market Size (2016-2027)
8.2 Asia-Pacific Cancer Stem Cells Market Size by Type
8.2.1 Asia-Pacific Cancer Stem Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Stem Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Stem Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Stem Cells Market Size by Application
8.3.1 Asia-Pacific Cancer Stem Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Stem Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Stem Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Stem Cells Market Size by Region
8.4.1 Asia-Pacific Cancer Stem Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Stem Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Stem Cells Market Size (2016-2027)
9.2 Latin America Cancer Stem Cells Market Size by Type
9.2.1 Latin America Cancer Stem Cells Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Stem Cells Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Stem Cells Market Size by Type (2016-2027)
9.3 Latin America Cancer Stem Cells Market Size by Application
9.3.1 Latin America Cancer Stem Cells Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Stem Cells Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Stem Cells Market Size by Application (2016-2027)
9.4 Latin America Cancer Stem Cells Market Size by Country
9.4.1 Latin America Cancer Stem Cells Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Stem Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Stem Cells Market Size (2016-2027)
10.2 Middle East & Africa Cancer Stem Cells Market Size by Type
10.2.1 Middle East & Africa Cancer Stem Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Stem Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Stem Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Stem Cells Market Size by Application
10.3.1 Middle East & Africa Cancer Stem Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Stem Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Stem Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Stem Cells Market Size by Country
10.4.1 Middle East & Africa Cancer Stem Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Stem Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cancer Stem Cells Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Details
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Cancer Stem Cells Introduction
11.2.4 Abbvie Revenue in Cancer Stem Cells Business (2016-2021)
11.2.5 Abbvie Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Details
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Cancer Stem Cells Introduction
11.3.4 Merck Kgaa Revenue in Cancer Stem Cells Business (2016-2021)
11.3.5 Merck Kgaa Recent Development
11.4 Bionomics
11.4.1 Bionomics Company Details
11.4.2 Bionomics Business Overview
11.4.3 Bionomics Cancer Stem Cells Introduction
11.4.4 Bionomics Revenue in Cancer Stem Cells Business (2016-2021)
11.4.5 Bionomics Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Cancer Stem Cells Introduction
11.5.4 Lonza Revenue in Cancer Stem Cells Business (2016-2021)
11.5.5 Lonza Recent Development
11.6 Stemline Therapeutics
11.6.1 Stemline Therapeutics Company Details
11.6.2 Stemline Therapeutics Business Overview
11.6.3 Stemline Therapeutics Cancer Stem Cells Introduction
11.6.4 Stemline Therapeutics Revenue in Cancer Stem Cells Business (2016-2021)
11.6.5 Stemline Therapeutics Recent Development
11.7 Miltenyi Biotec
11.7.1 Miltenyi Biotec Company Details
11.7.2 Miltenyi Biotec Business Overview
11.7.3 Miltenyi Biotec Cancer Stem Cells Introduction
11.7.4 Miltenyi Biotec Revenue in Cancer Stem Cells Business (2016-2021)
11.7.5 Miltenyi Biotec Recent Development
11.8 Promocell
11.8.1 Promocell Company Details
11.8.2 Promocell Business Overview
11.8.3 Promocell Cancer Stem Cells Introduction
11.8.4 Promocell Revenue in Cancer Stem Cells Business (2016-2021)
11.8.5 Promocell Recent Development
11.9 Macrogenics
11.9.1 Macrogenics Company Details
11.9.2 Macrogenics Business Overview
11.9.3 Macrogenics Cancer Stem Cells Introduction
11.9.4 Macrogenics Revenue in Cancer Stem Cells Business (2016-2021)
11.9.5 Macrogenics Recent Development
11.10 Oncomed Pharmaceuticals
11.10.1 Oncomed Pharmaceuticals Company Details
11.10.2 Oncomed Pharmaceuticals Business Overview
11.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Introduction
11.10.4 Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2016-2021)
11.10.5 Oncomed Pharmaceuticals Recent Development
11.11 Irvine Scientific
11.11.1 Irvine Scientific Company Details
11.11.2 Irvine Scientific Business Overview
11.11.3 Irvine Scientific Cancer Stem Cells Introduction
11.11.4 Irvine Scientific Revenue in Cancer Stem Cells Business (2016-2021)
11.11.5 Irvine Scientific Recent Development
11.12 Stemcell Technologies
11.12.1 Stemcell Technologies Company Details
11.12.2 Stemcell Technologies Business Overview
11.12.3 Stemcell Technologies Cancer Stem Cells Introduction
11.12.4 Stemcell Technologies Revenue in Cancer Stem Cells Business (2016-2021)
11.12.5 Stemcell Technologies Recent Development
11.13 Sino Biological
11.13.1 Sino Biological Company Details
11.13.2 Sino Biological Business Overview
11.13.3 Sino Biological Cancer Stem Cells Introduction
11.13.4 Sino Biological Revenue in Cancer Stem Cells Business (2016-2021)
11.13.5 Sino Biological Recent Development
11.14 Biotime
11.14.1 Biotime Company Details
11.14.2 Biotime Business Overview
11.14.3 Biotime Cancer Stem Cells Introduction
11.14.4 Biotime Revenue in Cancer Stem Cells Business (2016-2021)
11.14.5 Biotime Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Stem Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Culturing
Table 3. Key Players of Cell Separation
Table 4. Key Players of Cell Analysis
Table 5. Key Players of Molecular Analysis
Table 6. Key Players of Others
Table 7. Global Cancer Stem Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Stem Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Stem Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Cancer Stem Cells Market Share by Regions (2016-2021)
Table 11. Global Cancer Stem Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Cancer Stem Cells Market Share by Regions (2022-2027)
Table 13. Cancer Stem Cells Market Trends
Table 14. Cancer Stem Cells Market Drivers
Table 15. Cancer Stem Cells Market Challenges
Table 16. Cancer Stem Cells Market Restraints
Table 17. Global Cancer Stem Cells Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Cancer Stem Cells Market Share by Players (2016-2021)
Table 19. Global Top Cancer Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cells as of 2020)
Table 20. Ranking of Global Top Cancer Stem Cells Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Cancer Stem Cells Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Stem Cells Product Solution and Service
Table 24. Date of Enter into Cancer Stem Cells Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Cancer Stem Cells Revenue Market Share by Type (2016-2021)
Table 28. Global Cancer Stem Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Cancer Stem Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Cancer Stem Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Cancer Stem Cells Revenue Market Share by Application (2016-2021)
Table 32. Global Cancer Stem Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Cancer Stem Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Cancer Stem Cells Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Cancer Stem Cells Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Stem Cells Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Stem Cells Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Stem Cells Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Cancer Stem Cells Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Cancer Stem Cells Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Cancer Stem Cells Market Size by Country (2022-2027) & (US$ Million)
Table 64. Thermo Fisher Scientific Company Details
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Cancer Stem Cells Product
Table 67. Thermo Fisher Scientific Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Abbvie Company Details
Table 70. Abbvie Business Overview
Table 71. Abbvie Cancer Stem Cells Product
Table 72. Abbvie Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 73. Abbvie Recent Development
Table 74. Merck Kgaa Company Details
Table 75. Merck Kgaa Business Overview
Table 76. Merck Kgaa Cancer Stem Cells Product
Table 77. Merck Kgaa Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 78. Merck Kgaa Recent Development
Table 79. Bionomics Company Details
Table 80. Bionomics Business Overview
Table 81. Bionomics Cancer Stem Cells Product
Table 82. Bionomics Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 83. Bionomics Recent Development
Table 84. Lonza Company Details
Table 85. Lonza Business Overview
Table 86. Lonza Cancer Stem Cells Product
Table 87. Lonza Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 88. Lonza Recent Development
Table 89. Stemline Therapeutics Company Details
Table 90. Stemline Therapeutics Business Overview
Table 91. Stemline Therapeutics Cancer Stem Cells Product
Table 92. Stemline Therapeutics Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 93. Stemline Therapeutics Recent Development
Table 94. Miltenyi Biotec Company Details
Table 95. Miltenyi Biotec Business Overview
Table 96. Miltenyi Biotec Cancer Stem Cells Product
Table 97. Miltenyi Biotec Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 98. Miltenyi Biotec Recent Development
Table 99. Promocell Company Details
Table 100. Promocell Business Overview
Table 101. Promocell Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 102. Promocell Recent Development
Table 103. Macrogenics Company Details
Table 104. Macrogenics Business Overview
Table 105. Macrogenics Cancer Stem Cells Product
Table 106. Macrogenics Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 107. Macrogenics Recent Development
Table 108. Oncomed Pharmaceuticals Company Details
Table 109. Oncomed Pharmaceuticals Business Overview
Table 110. Oncomed Pharmaceuticals Cancer Stem Cells Product
Table 111. Oncomed Pharmaceuticals Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 112. Oncomed Pharmaceuticals Recent Development
Table 113. Irvine Scientific Company Details
Table 114. Irvine Scientific Business Overview
Table 115. Irvine Scientific Cancer Stem Cells Product
Table 116. Irvine Scientific Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 117. Irvine Scientific Recent Development
Table 118. Stemcell Technologies Company Details
Table 119. Stemcell Technologies Business Overview
Table 120. Stemcell Technologies Cancer Stem Cells Product
Table 121. Stemcell Technologies Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 122. Stemcell Technologies Recent Development
Table 123. Sino Biological Company Details
Table 124. Sino Biological Business Overview
Table 125. Sino Biological Cancer Stem Cells Product
Table 126. Sino Biological Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 127. Sino Biological Recent Development
Table 128. Biotime Company Details
Table 129. Biotime Business Overview
Table 130. Biotime Cancer Stem Cells Product
Table 131. Biotime Revenue in Cancer Stem Cells Business (2016-2021) & (US$ Million)
Table 132. Biotime Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Stem Cells Market Share by Type: 2020 VS 2027
Figure 2. Cell Culturing Features
Figure 3. Cell Separation Features
Figure 4. Cell Analysis Features
Figure 5. Molecular Analysis Features
Figure 6. Others Features
Figure 7. Global Cancer Stem Cells Market Share by Application: 2020 VS 2027
Figure 8. Breast Cancer Diagnosis and Treatment Case Studies
Figure 9. Prostate Cancer Diagnosis and Treatment Case Studies
Figure 10. Colorectal Cancer Diagnosis and Treatment Case Studies
Figure 11. Lung Cancer Diagnosis and Treatment Case Studies
Figure 12. Others Case Studies
Figure 13. Cancer Stem Cells Report Years Considered
Figure 14. Global Cancer Stem Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Cancer Stem Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Cancer Stem Cells Market Share by Regions: 2020 VS 2027
Figure 17. Global Cancer Stem Cells Market Share by Regions (2022-2027)
Figure 18. Global Cancer Stem Cells Market Share by Players in 2020
Figure 19. Global Top Cancer Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Stem Cells as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Cancer Stem Cells Revenue in 2020
Figure 21. Global Cancer Stem Cells Revenue Market Share by Type (2016-2021)
Figure 22. Global Cancer Stem Cells Revenue Market Share by Type (2022-2027)
Figure 23. North America Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Cancer Stem Cells Market Share by Type (2016-2027)
Figure 25. North America Cancer Stem Cells Market Share by Application (2016-2027)
Figure 26. North America Cancer Stem Cells Market Share by Country (2016-2027)
Figure 27. United States Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Cancer Stem Cells Market Share by Type (2016-2027)
Figure 31. Europe Cancer Stem Cells Market Share by Application (2016-2027)
Figure 32. Europe Cancer Stem Cells Market Share by Country (2016-2027)
Figure 33. Germany Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Cancer Stem Cells Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Cancer Stem Cells Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Cancer Stem Cells Market Share by Region (2016-2027)
Figure 43. China Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Cancer Stem Cells Market Share by Type (2016-2027)
Figure 51. Latin America Cancer Stem Cells Market Share by Application (2016-2027)
Figure 52. Latin America Cancer Stem Cells Market Share by Country (2016-2027)
Figure 53. Mexico Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Cancer Stem Cells Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Cancer Stem Cells Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Cancer Stem Cells Market Share by Country (2016-2027)
Figure 59. Turkey Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Cancer Stem Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 63. Abbvie Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 64. Merck Kgaa Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 65. Bionomics Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 66. Lonza Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 67. Stemline Therapeutics Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 68. Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 69. Promocell Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 70. Macrogenics Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 71. Oncomed Pharmaceuticals Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 72. Irvine Scientific Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 73. Stemcell Technologies Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 74. Sino Biological Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 75. Biotime Revenue Growth Rate in Cancer Stem Cells Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のがん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through gen…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…